Protective effects and mechanisms of a probiotic bacterium Lactobacillus rhamnosus against experimental Edwardsiella tarda infection in tilapia (Oreochromis niloticus).
- 2006-10
- Veterinary Immunology and Immunopathology 113(3-4)
- N. Pirarat
- Takeshi Kobayashi
- T. Katagiri
- M. Maita
- M. Endo
- PubMed: 16870266
- DOI: 10.1016/J.VETIMM.2006.06.003
Abstract
In recent years, probiotics, especially lactic acid bacteria, have been used as dietary supplements to protect fish from various infections. Here, we examined the protective effects of Lactobacillus rhamnosus against experimental Edwardsiella tarda infection in tilapia (Oreochromis niloticus). Cumulative mortality was significantly lower in probiotic-supplemented fish than in control fish. In a histopathological survey, pyogranulomatous responses were observed at an earlier stage and to a greater extent in the probiotic-supplemented fish than in the control fish. Immunohistochemistry using an anti-E. tarda antibody revealed a larger number of positive signals in pyogranuloma-participating cells, indicating an enhanced phagocytic ability. Alternative complement activity was significantly higher in the probiotic groups than in the control. These results suggest that L. rhamnosus enhanced the alternative complement system of the fish, enabling phagocytic cell aggregation, increasing phagocytic activity and subsequently protecting the fish from acute septicemic death by E. tarda infection. Prevention of thymic necrosis by the probiotic supplement seems to minimize immunosuppression and to initiate an immune response against edwardsiellosis.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Lactobacillus rhamnosus | Improved Phagocytic Activity | Beneficial | Moderate |
Lactobacillus rhamnosus | Increased Alternative Complement Activity | Beneficial | Moderate |
Lactobacillus rhamnosus | Reduced Colitis-Related Mortality | Beneficial | Large |
Lactobacillus rhamnosus | Reduced Thymic Necrosis | Beneficial | Moderate |
Lactobacillus rhamnosus DSM33560 | Improved Phagocytic Function | Beneficial | Large |
Lactobacillus rhamnosus DSM33560 | Increased Alternative Complement Activity | Beneficial | Moderate |
Lactobacillus rhamnosus DSM33560 | Reduced Colitis-Related Mortality | Beneficial | Large |
Lactobacillus rhamnosus DSM33560 | Reduced Thymic Necrosis | Beneficial | Moderate |